
Glioma drug combo turns tumours hot
Swiss researchers have shrinked one of the most lethal and untreatable types of cancer in mice using a combination treatment that proved safe in five...

Genmab and argenx combine antibody know-how
Genmab A/S and argenx will start their collaboration jointly launching two antibody programmes in immunology and oncology with the...

mbiomics GmbH cashes in €13m in Series A financing
High-Tech Gründerfonds (HTGF) and the state bank Bayern Kapital joined the funding round together with private seed investors.The start-up company...

Medigene licences CD40L-CD28 costimulatory switch receptor
Medigene has licences the global exclusive rights for CD40L-CD28 costimulatory switch receptor from the Helmholtz Centre Munich. Financial details...

FAO presents food safety assessment on cell-based protein products
With more than 100 companies, including Israel's Aleph Farms, Holland's Mosa Meat and the UK's Higher Steaks Ltd., active in the future market of...

Oculis lists at Nasdaq through SPAC merger
Upon closing of the $104m SPAC deal with European Biotech Acquisition Corp, Oculis had a pro-forma enterprise value of approximately $220m and a cash...

LSP Dementia Fund closes at €260m
Investors included the Alzheimer’s Association, the European Investment Fund EIF, several unnamed global pharmaceutical, and insurance companies,...